AstraZeneca’s COVID-19 vaccine will be tested at an NYU Langone trial site in Long Island, in addition to four other sites in New York City. The NYU Langone’s Vaccine Center is seeking to enroll 1,000 participants aged 18 to 85 to enroll in the phase III large-scale clinical trial, which is sponsored by the National Institutes of Health. This trial is part of the ongoing 30,000-person trial of the vaccine being tested globally. With our headquarters in Allentown, Pennsylvania and 21 strategically located depots around the world, Yourway is well-positioned to distribute clinical trial supplies for even the most critical and extensive trials.